Improving the production of malaria vaccines using mosquitoes and lab methods
Modularizing manufacture of PfSPZ vaccines: ookinete production for PfSPZ manufacture in mosquitoes and in vitro
This study is working on making malaria vaccines easier and cheaper to produce, so that more people can get a reliable shot to help prevent malaria caused by the Plasmodium falciparum parasite.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanaria, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-10922782 on NIH RePORTER |
What this research studies
This research focuses on enhancing the manufacturing process of PfSPZ vaccines, which are designed to prevent malaria caused by the Plasmodium falciparum parasite. The approach involves optimizing the production of ookinetes, a crucial stage in the vaccine manufacturing process, both in mosquitoes and in bioreactors. By improving efficiency and reducing costs, the goal is to make these vaccines more accessible and effective for global use. Patients may benefit from a more reliable and affordable malaria vaccine as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in malaria-endemic regions who are at risk of Plasmodium falciparum infection.
Not a fit: Patients who do not reside in malaria-endemic areas or those who are not at risk of malaria infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and widely available malaria vaccines, significantly reducing malaria infections.
How similar studies have performed: Previous research has shown promising results in vaccine efficacy against malaria, indicating that this approach has potential for success.
Where this research is happening
Rockville, United States
- Sanaria, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Hoffman, Stephen Lev — Sanaria, INC.
- Study coordinator: Hoffman, Stephen Lev
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.